The July 7, 2022 issue of Nikkei Biotech published an article about the launch of our all-in-one AI drug discovery platform “Elix Discovery™” and an interview with CEO Shinya Yuki. This platform is already provided to Kaken Pharmaceutical Co., Ltd.
The article also introduced our recent announcement of collaboration with DeNA Life Science.
https://bio.nikkeibp.co.jp/atcl/news/p1/22/07/06/09686/

Please refer to the following news releases of Elix and Kaken for more details.

News release of Elix
Elix launches “Elix Discovery™,” the only all-in-one AI drug discovery platform that provides everything from property prediction and molecular design to consulting and implementation support
Elix and DeNA Life Science agree in principle to cooperate

News release of Kaken
Kaken introduced “Elix Discovery™“, an AI Drug Discovery Platform